Is today’s surge in Dermata Therapeutics (DRMA) justified ?

0
Dermata Therapeutics, Inc. (Nasdaq:DRMA) is making significant strides with its focus on medical and aesthetic skin conditions. Recently, Dermata announced the successful...

Janux Therapeutics Reports Breakthrough in Prostate Cancer Treatment with JANX007

0
In a significant development from San Diego, Janux Therapeutics, Inc. (NASDAQ: JANX) has released an update on its groundbreaking JANX007 clinical program,...

NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for...

0
NovoCure Limited (NASDAQ: NVCR) achieved a major milestone with the announcement of positive results from its pivotal Phase 3 PANOVA-3 trial, conducted...

Popular News

MAKE IT MODERN

LATEST REVIEWS

AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) Receive Letter From the...

0
AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) announced that the Nasdaq Stock Department LLC's Listing Qualifications Department sent a staff determination letter...

MAKE IT MODERN

PERFORMANCE TRAINING

Scientists working in a modern biotechnology laboratory, conducting cutting-edge research and developing innovative treatments

Y-mAbs Therapeutics Inc (YMAB) could be an acquisition target

0
Y-mAbs Therapeutics, Inc. (YMAB) opened at $4.39. With a bid of $5.10 x 2200 and an ask of $5.25 x 1400, the...

Osmotica Pharmaceuticals plc (NASDAQ: OSMT) Enters a Note Purchase Agreement And Prices $35 Million...

0
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) has entered a note purchase agreement with Athyrium Capital Management-managed funds for around $100 million senior secured notes. Financing offers...

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Disclosed Its Findings on Its Latest Long COVID...

0
Tonix Pharmaceutical Holding Corporation (NASDAQ: TNXP) recently announced the findings of its recent experimental research that focused on 50,000 individuals that carried the prognosis...

Galecto Inc (NASDAQ: GLTO) Enrolls Patients in GULLIVER-2 Study

0
Galecto Inc (NASDAQ: GLTO) has enrolled patients for the second and third parts of its Phase Ib/IIa GB1211, GULLIVER-2 study. The company...

OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply Of Baggage Screening...

0
The commonwealth government of Australia awarded an order worth $5 million to OSI Systems, Inc. (NASDAQ:OSIS). As per the terms of the contract, OSI’s...

MAKE IT MODERN

POPULAR

romabet mahbet پین باهیس bettingmagazine.org بت کارت یاس بت yekbet megapari onjabet alvinbet betboro betfa بت فوروارد 1xbet 1win betwinner 4shart.com 1xbetgiris.cam وان کیک بت وین بت ریتزوبت 1xbet-ir.com.co وان ایکس بت بت فوروارد